Beta-Blockers [phsu]
Hypertension [dsyn]
Update [tmco]
Published [ocac]
Assessed [acty]
Beta [plnt]
Blockade [ftcn]
First-Line Therapy [topp]
Hypertension [dsyn]
objectives [inpr]
Quantify [qnco]
Effectiveness [qlco]
Safety [hcpp]
Beta-Blockers [phsu]
Morbidity [qnco]
Mortality [qnco]
endpoints [qlco]
Adults [aggp]
Hypertension [dsyn]
search [inpr]
Methods [inpr]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
MEDLINE [inpr]
Reference [idcn]
List [cnce]
Previous [tmco]
reviews [inpr]
eligible [idcn]
Published [ocac]
Previous [tmco]
search [inpr]
Conduct [inbe]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
Duration [tmco]
Assessed [acty]
effects [qlco]
Beta-Blockers [phsu]
Compared [acty]
placebo [topp]
Drugs [phsu]
First-Line Therapy [topp]
Hypertension [dsyn]
Mortality [qnco]
Morbidity [qnco]
Adults [aggp]
Data Collection [resa]
Select [acty]
Extracted [topp]
Duplicate [ftcn]
study results [fndg]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Combined [qlco]
Fixed [fndg]
effects [qlco]
RANDOM [resa]
Appropriate [qlco]
Main [qlco]
included [ftcn]
Controlled [ftcn]
Trial [resa]
Compared [acty]
Beta-Blockers [phsu]
placebo [topp]
Trial [resa]
N NOS [aapp, imft]
Diuretics [phsu]
Trial [resa]
N NOS [aapp, imft]
Calcium Channel Blockers [phsu]
Trial [resa]
N NOS [aapp, imft]
Renin-angiotensin system [bdsy]
Ras Inhibitor [phsu]
Trial [resa]
N NOS [aapp, imft]
Quarter [qnco]
participants [popg]
Beta-Blockers [phsu]
Atenolol [orch, phsu]
High Risk [qlco]
Bias [idcn]
Various [irda]
limitations [ftcn]
Study Design [resa]
Conduct [inbe]
Data Analysis [ocac]
Mortality [qnco]
Beta-Blockers [phsu]
placebo [topp]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Diuretics [phsu]
Ras Inhibitor [phsu]
Beta-Blockers [phsu]
Compared [acty]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Cardiovascular disease [dsyn]
Beta-Blockers [phsu]
Compared [acty]
placebo [topp]
Risk Ratios [qnco]
Confidence Intervals [qnco]
reflected [menp]
Decrease [qlco]
Stroke risk [inpr]
Ratios [qnco]
Confidence Intervals [qnco]
coronary heart disease [dsyn]
Beta-Blockers [phsu]
placebo [topp]
Withdrawal [acty]
Assigned [ftcn]
treatment [ftcn]
adverse events [fndg]
Beta-Blockers [phsu]
placebo [topp]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Beta-Blockers [phsu]
Cardiovascular disease [dsyn]
worse [qlco]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Diuretics [phsu]
Ras Inhibitor [phsu]
Addition [ftcn]
Stroke [dsyn]
Beta-Blockers [phsu]
Compared [acty]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Ras Inhibitor [phsu]
Risk Ratios [qnco]
Confidence Intervals [qnco]
coronary heart disease [dsyn]
Beta-Blockers [phsu]
Diuretics [phsu]
Ras Inhibitor [phsu]
participants [popg]
Beta-Blockers [phsu]
Likely [qlco]
Discontinue [fndg]
treatment [ftcn]
adverse events [fndg]
Ras Inhibitor [phsu]
Risk Ratios [qnco]
Confidence Intervals [qnco]
Diuretics [phsu]
Authors [prog]
Conclusions [idcn]
Initiate [idcn]
treatment [ftcn]
Hypertension [dsyn]
Beta-Blockers [phsu]
???lead [elii, hops]
reductions [npop]
Cardiovascular disease [dsyn]
effects [qlco]
Mortality [qnco]
effects [qlco]
Beta-Blockers [phsu]
Inferior [spco]
Anti-Hypertensive Drugs [phsu]
Grade [clas]
Quality [qlco]
True [qlco]
Beta-Blockers [phsu]
Estimate [qnco]
effects [qlco]
Quality [qlco]
Sub- [spco]
Beta-Blockers [phsu]
Beta-Blockers [phsu]
Differential [qlco]
effects [qlco]
Young [tmco]
Elderly [popg]
Patients [podg]
